MAPK14 and cancer: IGFBP5 appears to exert a specific inhibitory effect on melanoma growth and metastasis through inhibition of the ERK1/2 and P38-MAPK pathways, therefore it may qualify as a useful therapeutic target against melanoma and other cancers [67].